44 Ken Griffin GSK Plc Trades
Ken Griffin acquired 799 Thousand GSK Plc shares worth $29.3 Million. That's 0.03% of their equity portfolio (676th largest holding). The first GSK Plc trade was made in Q2 2013. Since then Ken Griffin bought shares 56 more times and sold shares on 53 occasions. The investor's estimated purchase price is $30.6 Million, resulting in a loss of 4.3%.
Avg closing price
Price range
Sold 68.1% shares (-393 Thousand shares)
Q4 2024
Avg closing price
$35.92
Price range
$33.35
-
$40.30
Increased shares by 4072.7% (+563 Thousand shares)
Q3 2024
Avg closing price
$40.92
Price range
$38.21
-
$44.26
Sold 93.6% shares (-204 Thousand shares)
Q2 2024
Avg closing price
$42.07
Price range
$38.50
-
$45.78
Increased shares by 83.7% (+99 Thousand shares)
Q1 2024
Avg closing price
$41.24
Price range
$37.51
-
$43.58
Sold 77.8% shares (-414 Thousand shares)
Q4 2023
Avg closing price
$35.90
Price range
$34.17
-
$37.56
Increased shares by 1835.2% (+505 Thousand shares)
Q3 2023
Avg closing price
$35.49
Price range
$33.81
-
$38.07
Sold 90.1% shares (-250 Thousand shares)
Q2 2023
Avg closing price
$35.87
Price range
$33.60
-
$38.32
Sold 70.3% shares (-656 Thousand shares)
Q1 2023
Avg closing price
$34.99
Price range
$33.50
-
$36.43
Sold 74.9% shares (-2.78 Million shares)
Q4 2022
Avg closing price
$33.31
Price range
$30.00
-
$37.92
Increased shares by 177.2% (+2.37 Million shares)
Q3 2022
Avg closing price
$36.31
Price range
$28.66
-
$43.91
Increased shares by 12.8% (+152 Thousand shares)
Q2 2022
Avg closing price
$44.17
Price range
$41.24
-
$46.85
Increased shares by 17.6% (+178 Thousand shares)
Q1 2022
Avg closing price
$43.45
Price range
$39.46
-
$46.82
Increased shares by 103.5% (+513 Thousand shares)
Q4 2021
Avg closing price
$41.61
Price range
$38.13
-
$44.44
Sold 25.6% shares (-171 Thousand shares)
Q3 2021
Avg closing price
$40.18
Price range
$38.05
-
$42.33
Sold 39.8% shares (-442 Thousand shares)
Q2 2021
Avg closing price
$38.44
Price range
$35.82
-
$40.66
Increased shares by 189.7% (+726 Thousand shares)
Q1 2021
Avg closing price
$36.31
Price range
$33.61
-
$39.24
Increased shares by 1141.0% (+352 Thousand shares)
Q3 2020
Avg closing price
$40.08
Price range
$37.38
-
$42.16
Sold 91.8% shares (-347 Thousand shares)
Q2 2020
Avg closing price
$41.04
Price range
$37.14
-
$42.74
Increased shares by 843.8% (+338 Thousand shares)
Q1 2020
Avg closing price
$42.67
Price range
$31.85
-
$47.89
Sold 37.4% shares (-24 Thousand shares)
Q4 2019
Avg closing price
$44.50
Price range
$41.19
-
$47.32
News about GSK Plc - ADR and Ken Griffin
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
Ken Griffin 's hedge fund Citadel has placed a £305 million ($390 million) short bet against GSK PLC GSK, marking the largest wager against the UK pharma gia...
Hedge Fund and Insider Trading News: Ken Griffin, Sanjay Shah, David Tepper, Stanley Druckenmiller, Michael Burry, Cevian Capital, Elliott Management, Millennium Management, Eisler Capital, Allogene Therapeutics Inc (ALLO), Carvana Co. (CVNA) and More
Billionaire Ken Griffin Goes Heavy On This Tech Stock, Increases Stake By 200% In Two Quarters (IBTimes) Big Asset Managers Including Morgan Stanley, Citadel...